Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Other Working Capital Changes (2019 - 2026)

BioScience Health Innovations has reported Other Working Capital Changes over the past 5 years, most recently at -$59841.0 for Q1 2026.

  • Quarterly Other Working Capital Changes fell 1661.58% to -$59841.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$39935.0 through Mar 2026, down 290.78% year-over-year, with the annual reading at $16509.0 for FY2025, 18.99% down from the prior year.
  • Other Working Capital Changes was -$59841.0 for Q1 2026 at BioScience Health Innovations, up from -$70153.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $227727.0 in Q2 2025 and troughed at -$137668.0 in Q3 2025.
  • The 3-year median for Other Working Capital Changes is -$3673.0 (2024), against an average of -$2869.0.
  • The largest YoY upside for Other Working Capital Changes was 13.98% in 2025 against a maximum downside of 2656.98% in 2025.
  • A 3-year view of Other Working Capital Changes shows it stood at $18945.0 in 2024, then tumbled by 470.3% to -$70153.0 in 2025, then grew by 14.7% to -$59841.0 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Other Working Capital Changes are -$59841.0 (Q1 2026), -$70153.0 (Q4 2025), and -$137668.0 (Q3 2025).